Exciting news for third-party payors: a second major opioid-related settlement is here! Leading pharmaceutical distributors have created a $300 million settlement fund, offering significant compensation for those impacted by the opioid crisis.
In Re: National Prescription Opiate Consultant Litigation (Case No. 1:17-md-2804)
Settlement Fund
$300 million
Class Period
January 1, 1996, through September 3, 2024
Claim Filing Deadline
June 20, 2025
Settling Defendants
Cencora, Inc. (f/k/a AmerisourceBergen Corporation), Cardinal Health, Inc., and McKesson Corporation
Overview
Three of the largest pharmaceutical distributors in the U.S. have agreed to a $300 million settlement in response to claims that they played a role in the national opioid crisis, resulting in significant costs for third-party payors related to opioid payments and the treatment of individuals affected by opioid-related conditions.
This settlement comes on the heels of the $78 million McKinsey National Prescription Opiate Consultant Settlement (filing deadline: December 15, 2024), which was the first opioid-related settlement exclusively for third-party payors. MCAG will be actively filing claims on behalf of its clients for both settlements.
Eligibility
All entities that paid and/or were reimbursed for (i) opioid prescription drugs manufactured, marketed, sold, distributed, or dispensed by any of the Defendants and/or Opioid Supply Chain Members for purposes other than resale, and/or (ii) paid or incurred costs for treatment related to the misuse, addiction, and/or overdose of opioid drugs, on behalf of individual beneficiaries, insureds, and/or members, during the time period from January 1, 1996 to September 3, 2024.
Recommended Next Steps
To complete your claim for this settlement, certain data is required. Please connect us with a member of your Benefits Department, and an MCAG representative will provide details on the necessary information to finalize your claim.
Need more information? Call MCAG at 1-800-355-0466 to learn more or CLICK HERE to complete our contact form and an MCAG representative will respond shortly.
Comments